This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2017-01-27PC CIMI POC Call Minutes"
Jump to navigation
Jump to search
(→Agenda) |
|||
Line 112: | Line 112: | ||
'''Minutes/Conclusions Reached:'''<br/> | '''Minutes/Conclusions Reached:'''<br/> | ||
− | * | + | * Preliminary discussion: how to make CIMI artifacts simple enough for users |
+ | * Question of model bindings: where to they go | ||
+ | ** Evaluations have question codes | ||
+ | ** Assertions have values | ||
+ | ** Assertion properties: semantic binding is metadata. Can/Should it be in instances? | ||
+ | *** Body site: FHIR property is <b>semantic equivalent</b> of LOINC body site, and of SCT Finding site in finding context | ||
+ | **** So we can leave the LOINC code out? Is there any recordkeeping or administrative reason to have it? | ||
+ | **** Yes, for ordered panels, not so much for sub-panels? | ||
+ | * Question of structure | ||
+ | ** Site has a code or an associated structure | ||
+ | ** How much do we need to worry about it here in the requirements stage vs design? | ||
+ | * Cardinality | ||
+ | ** Not just Tunneling but other properties may need to be 0:N, e.g., wound edge appearance, tunneling | ||
+ | ** If so, do we need to fragment body site for respective bits? Is this too much detail? | ||
+ | ** Tunneling has clock position: do we need some other way to designate sub-body-site? To assign an identifier? | ||
+ | * Clinicians want these properties to be their own Evaluations | ||
+ | ** maybe not Evaluation class, but to carry both question and answer. | ||
+ | * Model details | ||
+ | ** Remove Stage from pressure ulcer | ||
+ | ** Rename to Pressure Injury? | ||
===Meeting Outcomes=== | ===Meeting Outcomes=== |
Latest revision as of 16:37, 27 January 2017
Back to PC CIMI POC Minutes
Minutes Template
Meeting Information
HL7 PC-CIMI-POC Meeting Minutes Location: Phone |
Date: 2017-01-27 Time: 10:00-11:00 CT | ||
Facilitator | Jay Lyle | Note taker(s) | Jay Lyle |
Attendee | Name | Affiliation
| |
y | Richard Esmond | PenRad | |
y | Galen Mulrooney | JP Systems | |
y | Jay Lyle | JP Systems / VA | |
y | Larry McKnight | Cerner | |
y | Susan Matney | Intermountain | |
y | Joey Coyle | Intermountain | |
Gay Dolin | |||
Ash Davison | Intermountain | ||
Laura Heerman Langford | Intermountain | ||
Claude Nanjo | |||
Rob McClure | |||
Agenda
Agenda Topics
- LOINC gap: summarize gaps found so far; complete list
Minutes
Minutes/Conclusions Reached:
- Preliminary discussion: how to make CIMI artifacts simple enough for users
- Question of model bindings: where to they go
- Evaluations have question codes
- Assertions have values
- Assertion properties: semantic binding is metadata. Can/Should it be in instances?
- Body site: FHIR property is semantic equivalent of LOINC body site, and of SCT Finding site in finding context
- So we can leave the LOINC code out? Is there any recordkeeping or administrative reason to have it?
- Yes, for ordered panels, not so much for sub-panels?
- Body site: FHIR property is semantic equivalent of LOINC body site, and of SCT Finding site in finding context
- Question of structure
- Site has a code or an associated structure
- How much do we need to worry about it here in the requirements stage vs design?
- Cardinality
- Not just Tunneling but other properties may need to be 0:N, e.g., wound edge appearance, tunneling
- If so, do we need to fragment body site for respective bits? Is this too much detail?
- Tunneling has clock position: do we need some other way to designate sub-body-site? To assign an identifier?
- Clinicians want these properties to be their own Evaluations
- maybe not Evaluation class, but to carry both question and answer.
- Model details
- Remove Stage from pressure ulcer
- Rename to Pressure Injury?
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2012 Health Level Seven® International. All rights reserved.